Diagnosis and management of small intestinal bacterial overgrowth

Nutrition in Clinical Practice

Volumn 28, Issue 3, 2013, Pages 289-299

  Bohm, Matthew ^a   Siwiec, Robert M ^a   Wo, John M ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

bacteria; FODMAP; intestine, small; metagenome; microbiota; small intestinal bacterial overgrowth

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CIPROFLOXACIN; DOMPERIDONE; DOXYCYCLINE; ERYTHROMYCIN; METOCLOPRAMIDE; METRONIDAZOLE; NEOMYCIN; NORFLOXACIN; RIFAXIMIN; TETRACYCLINE; TRACE ELEMENT;

ABDOMINAL PAIN; ARTIFICIAL MILK; ASPIRATION; BACTERIAL OVERGROWTH; BACTERIUM CULTURE; BACTEROIDES; BACTEROIDETES; BIFIDOBACTERIUM; BLOATING; BREATH ANALYSIS; CELIAC DISEASE; CHRONIC PANCREATITIS; CLEARANCE; CLINICAL FEATURE; CLOSTRIDIUM; COLIFORM BACTERIUM; COLONY FORMING UNIT; DIARRHEA; DIET THERAPY; DNA SEQUENCE; ENTEROBACTER; ESCHERICHIA COLI; FLATULENCE; FOOD INTAKE; GASTRECTOMY BILLROTH I; HIGH THROUGHPUT SEQUENCING; HUMAN; IMMUNE DEFICIENCY; INTESTINE DISTENSION; INTESTINE FLORA; INTESTINE LOOP; INTESTINE MOTILITY; JEJUNUM; KLEBSIELLA; LIVER CIRRHOSIS; MACRONUTRIENT; MALABSORPTION; META ANALYSIS (TOPIC); NUTRITIONAL DEFICIENCY; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; ROUX Y ANASTOMOSIS; RUMINOCOCCUS; SENSITIVITY AND SPECIFICITY; SMALL INTESTINAL BACTERIAL OVERGROWTH; SMALL INTESTINE; SMALL INTESTINE DISEASE; STOMACH ACID; STOMACH ACID SECRETION; STOMACH PH; WEIGHT REDUCTION;

BACTERIA; FODMAP; INTESTINE, SMALL; METAGENOME; MICROBIOTA; SMALL INTESTINAL BACTERIAL OVERGROWTH;

ABDOMINAL PAIN; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BREATH TESTS; DIARRHEA; FLATULENCE; GASTROINTESTINAL MOTILITY; GRAM-NEGATIVE BACTERIA; HUMANS; IRRITABLE BOWEL SYNDROME; JEJUNUM; MICROBIOTA;

EID: 84877776019     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533613485882     Document Type: Review

References (64)

1. Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol. 2000 ; 95: 3503-3506
2. Sabate JM, Jouet P, Harnois F, et al. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg. 2008 ; 18: 371-377
3. Shanab AA, Scully P, Crosbie O, et al. Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with Toll-like receptor 4 expression and plasma levels of interleukin 8. Dig Dis Sci. 2011 ; 56: 1524-1534
4. Castiglione F, Rispo A, Di GE, et al. Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease. Aliment Pharmacol Ther. 2003 ; 18: 1107-1112
5. Rubio-Tapia A, Barton SH, Rosenblatt JE, Murray JA. Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol. 2009 ; 43: 157-161
6. Weaver LT, Austin S, Cole TJ. Small intestinal length: a factor essential for gut adaptation. Gut. 1991 ; 32: 1321-1323
7. Gibson PR, Shepherd SJ. Food choice as a key management strategy for functional gastrointestinal symptoms. Am J Gastroenterol. 2012 ; 107: 657-666
8. Riordan SM, McIver CJ, Walker BM, Duncombe VM, Bolin TD, Thomas MC. The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol. 1996 ; 91: 1795-1803
9. Yu D, Cheeseman F, Vanner S. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut. 2011 ; 60: 334-340
10. Parlesak A, Klein B, Schecher K, Bode JC, Bode C. Prevalence of small bowel bacterial overgrowth and its association with nutrition intake in nonhospitalized older adults. J Am Geriatr Soc. 2003 ; 51: 768-773
11. Choung RS, Ruff KC, Malhotra A, et al. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther. 2011 ; 33: 1059-1067
12. Trespi E, Ferrieri A. Intestinal bacterial overgrowth during chronic pancreatitis. Curr Med Res Opin. 1999 ; 15: 47-52
13. Gupta A, Dhiman RK, Kumari S, et al. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J Hepatol. 2010 ; 53: 849-855
14. Lupascu A, Gabrielli M, Lauritano EC, et al. Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther. 2005 ; 22: 1157-1160
15. Scarpellini E, Giorgio V, Gabrielli M, et al. Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study. J Pediatr. 2009 ; 155: 416-420
16. Ford AC, Spiegel BM, Talley NJ, Moayyedi P. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009 ; 7: 1279-1286
17. Posserud I, Stotzer PO, Bjornsson ES, Abrahamsson H, Simren M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut. 2007 ; 56: 802-808
18. Mackie RI, Sghir A, Gaskins HR. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr. 1999 ; 69: 1035S - 1045S
19. De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010 ; 107: 14691-14696
20. Simren M, Barbara G, Flint HJ, et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut. 2012 ; 62: 159-176
21. Husebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy. 2005 ; 51: 1-22
22. Camp JG, Kanther M, Semova I, Rawls JF. Patterns and scales in gastrointestinal microbial ecology. Gastroenterology. 2009 ; 136: 1989-2002
23. Simson JN, Kinder RB, Isaacs PE, Jourdan MH. Mucosal bridges of the oesophagus in Candida oesophagitis. Br J Surg. 1985 ; 72: 209-210
24. Fan X, Sellin JH. Review article: small intestinal bacterial overgrowth, bile acid malabsorption and gluten intolerance as possible causes of chronic watery diarrhoea. Aliment Pharmacol Ther. 2009 ; 29: 1069-1077
25. Giannella RA, Broitman SA, Zamcheck N. Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro. Gut. 1972 ; 13: 251-256
26. Kawaguchi H, Haruma K, Komoto K, Yoshihara M, Sumii K, Kajiyama G. Helicobacter pylori infection is the major risk factor for atrophic gastritis. Am J Gastroenterol. 1996 ; 91: 959-962
27. Husebye E, Skar V, Hoverstad T, Melby K. Fasting hypochlorhydria with gram positive gastric flora is highly prevalent in healthy old people. Gut. 1992 ; 33: 1331-1337
28. Fried M, Siegrist H, Frei R, et al. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut. 1994 ; 35: 23-26
29. Compare D, Pica L, Rocco A, et al. Effects of long-term PPI treatment on producing bowel symptoms and SIBO. Eur J Clin Invest. 2011 ; 41: 380-386
30. Lombardo L, Foti M, Ruggia O, Chiecchio A. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol. 2010 ; 8: 504-508
31. Shindo K, Machida M, Fukumura M, Koide K, Yamazaki R. Omeprazole induces altered bile acid metabolism. Gut. 1998 ; 42: 266-271
32. Ratuapli SK, Ellington TG, O'Neill MT, et al. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth. Am J Gastroenterol. 2012 ; 107: 730-735
33. Sutton DH, Harrell SP, Wo JM. Diagnosis and management of adult patients with chronic intestinal pseudoobstruction. Nutr Clin Pract. 2006 ; 21: 16-22
34. Meagher AP, Porter AJ, Rowland R, Ma G, Hoffmann DC. Jejunal diverticulosis. Aust N Z J Surg. 1993 ; 63: 360-366
35. Akhrass R, Yaffe MB, Fischer C, Ponsky J, Shuck JM. Small-bowel diverticulosis: perceptions and reality. J Am Coll Surg. 1997 ; 184: 383-388
36. Klaus J, Spaniol U, Adler G, Mason RA, Reinshagen M, von Tirpitz CC. Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's disease. BMC Gastroenterol. 2009 ; 9: 61
37. Ghoshal UC, Goel A, Ghoshal U, Jain M, Misra A, Choudhuri G. Chronic diarrhea and malabsorption due to hypogammaglobulinemia: a report on twelve patients. Indian J Gastroenterol. 2011 ; 30: 170-174
38. Pignata C, Budillon G, Monaco G, et al. Jejunal bacterial overgrowth and intestinal permeability in children with immunodeficiency syndromes. Gut. 1990 ; 31: 879-882
39. Riordan SM, McIver CJ, Wakefield D, Thomas MC, Duncombe VM, Bolin TD. Serum immunoglobulin and soluble IL-2 receptor levels in small intestinal overgrowth with indigenous gut flora. Dig Dis Sci. 1999 ; 44: 939-944
40. Shindo K, Machida M, Koide K, Fukumura M, Yamazaki R. Deconjugation ability of bacteria isolated from the jejunal fluid of patients with progressive systemic sclerosis and its gastric pH. Hepatogastroenterology. 1998 ; 45: 1643-1650
41. Corazza GR, Menozzi MG, Strocchi A, et al. The diagnosis of small bowel bacterial overgrowth: reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology. 1990 ; 98: 302-309
42. Kerckhoffs AP, Visser MR, Samsom M, et al. Critical evaluation of diagnosing bacterial overgrowth in the proximal small intestine. J Clin Gastroenterol. 2008 ; 42: 1095-1102
43. Pimentel M, Constantino T, Kong Y, Bajwa M, Rezaei A, Park S. A 14-day elemental diet is highly effective in normalizing the lactulose breath test. Dig Dis Sci. 2004 ; 49: 73-77
44. Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: the FODMAP approach. J Gastroenterol Hepatol. 2010 ; 25: 252-258
45. Ong DK, Mitchell SB, Barrett JS, et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol. 2010 ; 25: 1366-1373
46. Staudacher HM, Whelan K, Irving PM, Lomer MC. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet. 2011 ; 24: 487-495
47. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2003 ; 98: 412-419
48. Chang MS, Minaya MT, Cheng J, Connor BA, Lewis SK, Green PH. Double-blind randomized controlled trial of rifaximin for persistent symptoms in patients with celiac disease. Dig Dis Sci. 2011 ; 56: 2939-2946
49. Collins BS, Lin HC. Double-blind, placebo-controlled antibiotic treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain. J Pediatr Gastroenterol Nutr. 2011 ; 52: 382-386
50. Attar A, Flourie B, Rambaud JC, Franchisseur C, Ruszniewski P, Bouhnik Y. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology. 1999 ; 117: 794-797
51. Castiglione F, Rispo A, Di Girolamo E, et al. Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease. Aliment Pharmacol Ther. 2003 ; 18: 1107-1112
52. Lauritano EC, Gabrielli M, Scarpellini E, et al. Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole. Eur Rev Med Pharmacol Sci. 2009 ; 13: 111-116
53. Di Stefano M, Malservisi S, Veneto G, Ferrieri A, Corazza GR. Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2000 ; 14: 551-556
54. Pimentel M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011 ; 364: 22-32
55. Lauritano EC, Gabrielli M, Scarpellini E, et al. Small intestinal bacterial overgrowth recurrence after antibiotic therapy. Am J Gastroenterol. 2008 ; 103: 2031-2035
56. Kaye SA, Lim SG, Taylor M, Patel S, Gillespie S, Black CM. Small bowel bacterial overgrowth in systemic sclerosis: detection using direct and indirect methods and treatment outcome. Br J Rheumatol. 1995 ; 34: 265-269
57. Lisowska A, Pogorzelski A, Oracz G, et al. Oral antibiotic therapy improves fat absorption in cystic fibrosis patients with small intestine bacterial overgrowth. J Cyst Fibros. 2011 ; 10: 418-421
58. Sajjad A, Mottershead M, Syn WK, Jones R, Smith S, Nwokolo CU. Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2005 ; 22: 291-299
59. Tarnopolsky MA, Pearce E, Matteliano A, James C, Armstrong D. Bacterial overgrowth syndrome in myotonic muscular dystrophy is potentially treatable. Muscle Nerve. 2010 ; 42: 853-855
60. Lewis SJ, Potts LF, Malhotra R, Mountford R. Small bowel bacterial overgrowth in subjects living in residential care homes. Age Ageing. 1999 ; 28: 181-185
61. Marie I, Ducrotte P, Denis P, Menard JF, Levesque H. Small intestinal bacterial overgrowth in systemic sclerosis. Rheumatology (Oxford). 2009 ; 48: 1314-1319
62. Di Stefano M, Miceli E, Missanelli A, Mazzocchi S, Corazza GR. Absorbable vs. non-absorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome. Aliment Pharmacol Ther. 2005 ; 21: 985-992
63. Yang J, Lee HR, Low K, Chatterjee S, Pimentel M. Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS. Dig Dis Sci. 2008 ; 53: 169-174
64. Peralta S, Cottone C, Doveri T, Almasio PL, Craxi A. Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with rifaximin. World J Gastroenterol. 2009 ; 15: 2628-2631